Liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis

SC Samya Van Coillie
ES Emily Van San
IG Ines Goetschalckx
BW Bartosz Wiernicki
BM Banibrata Mukhopadhyay
WT Wulf Tonnus
SC Sze Men Choi
RR Ria Roelandt
CD Catalina Dumitrascu
LL Ludwig Lamberts
GD Geert Dams
WW Wannes Weyts
JH Jelle Huysentruyt
BH Behrouz Hassannia
II Irina Ingold
SL Suhas Lele
EM Evelyne Meyer
MB Maya Berg
RS Ruth Seurinck
YS Yvan Saeys
AV An Vermeulen
AN Alexander L. N. van Nuijs
MC Marcus Conrad
AL Andreas Linkermann
MR Mohan Rajapurkar
PV Peter Vandenabeele
EH Eric Hoste
KA Koen Augustyns
TB Tom Vanden Berghe
request Request a Protocol
ask Ask a question
Favorite

UAMC-3203 detection in plasma, whole blood, and tissue homogenates (lysed in PBS using a Precellys 24 Tissue Homogenizer (Bertin Instruments)) was performed on an Agilent 1200 series LC system connected to a 6410 triple quadrupole mass spectrometer from Agilent Technologies (Waldbronn, Germany) with electrospray ionization (ESI) interface operated in positive ionization mode. Chromatographic separation was carried out on a Kinetex Biphenyl column (100 × 2.1 mm, 2.6 μm; Phenomenex (Utrecht, the Netherlands)). The mobile phase consisted of (A) ultrapure water with 0.1% formic acid and (B) acetonitrile/ultrapure water (90/10) with 0.1% formic acid, in gradient at 0.3 mL/min. The ESI source parameters were gas temperature 350 °C, gas flow 10 L/min, nebulizer pressure 35 psi, and capillary voltage 4000 V. Data acquisition was done in multiple reaction monitoring modes (MRM). Confirmation of UAMC-3203 was done using three MRM transitions; the most abundant transition was used as a quantifier (Q) and the other two were used as a qualifier (q). Qualifier/quantifier ratios (q/Q) were calculated for each sample and had to be within ±20% of the q/Q ratio observed in the calibrators. In addition, the retention time of the compound in samples could not deviate >10% of the retention time observed in the calibrators.

UAMC-3203 and nordiazepam-D5 (Cerilliant Corporation; Texas, US) as internal standard (IS) were diluted in LC-MS grade methanol (Fisher Scientific). A volume of 100 µL sample was spiked with 20 µL IS (200 ng/mL), followed by the addition of 150 µL acetonitrile for plasma and blood. For tissue, 500 µL acetonitrile with 0.1% formic acid was added. Afterward, the mixture was vortexed (2 min, 2000 rpm) and centrifuged (10 min, 9168 g resp. 17968 gfor plasma and blood resp. tissue). The supernatant of plasma and whole blood was then transferred to a 2 mL tube with a 0.20 μm centrifugal filter (VWR, Avantor, Randor, PA, USA). The supernatant of tissue was evaporated under a stream of nitrogen at 40 °C, reconstituted in 100 μL acetonitrile/ultrapure water (90/10) with 0.1% formic acid, and transferred to a 2 mL tube with a 0.20 μm centrifugal filter. All samples were then centrifuged (5 min, 9168 g resp. 10 min, 17968 g for plasma and blood resp. tissue), after which the final extract was transferred to an autosampler vial with a glass insert. Seven-level calibration curves were prepared in blank mouse plasma or whole blood, covering a linear range from 10 ng/mL to 700 ng/mL. Five-level calibration curves were prepared in blank homogenized mouse tissue matrix covering a linear range from 20 ng/mL to 4000 ng/mL. The measured concentrations in ng/mL were further normalized using the weight of the tissue used for homogenization to obtain final concentrations of UAMC-3203 expressed in µg/g.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A